Protalix BioTherapeutics, Inc. 4
4 · Protalix BioTherapeutics, Inc. · Filed Aug 15, 2014
Insider Transaction Report
Form 4
Bronfeld Zeev
Director10% Owner
Transactions
- Sale
Common Stock
2014-08-13$2.47/sh−4,400,000$10,868,000→ 10,066,319 total(indirect: By Trust)
Footnotes (1)
- [F1]All shares of Common Stock are held by Biocell Ltd. Mr. Bronfeld disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein.